Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-24-006410

President and CEO acquired 159,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stergiou Angelos M. President and CEO 2024-01-22 Grant or award +159,000 376,421 D
Derivatives
Stergiou Angelos M. President and CEO 2024-01-22 Grant or award · Stock Option (Right to Buy) +238,500 238,500 D
Loading xslF345X05/tm243935-5_4seq1.xml…